Hong Kong Stock Exchange's Liu Ying: Since the launch of Chapter 18A in 2018, 90 biotech companies have listed in Hong Kong
The Hong Kong Stock Exchange has seen significant activity under its Chapter 18A listing rules, with 90 biotech companies listing and raising HK$142.9 billion since 2018. Additionally, the Chapter 18C mechanism for special technology companies has facilitated listings for AI, robotics, and autonomous driving firms. In contrast, the A-share market experienced a broad decline, with over 4000 stocks falling, despite some gains in industrial gases and semiconductors. AI
IMPACT Facilitates capital for AI and tech companies, potentially accelerating innovation and market growth.